This also partly explains the absence of significant differences in blood NFL levels between FTLDSs and ODs in stratum B studies, another reason being the inclusion of CJD cases amongst patients with ODs in the investigation of Halbgebauer et al. The gene discussed is NEFL; the disease is Creutzfeldt Jacob disease.